CAI vs CLOV
Caris Life Sciences, Inc. Common Stock (CAI) versus Clover Health Investments Corp (CLOV) — a side-by-side from cached financials, not a winner call.
Caris Life Sciences, Inc. Common Stock (CAI) is a biotechnology company listed on NASDAQ.
Clover Health Investments Corp (CLOV) is a healthcare plans company listed on US.
Latest reported CAI revenue for 2025-09-30 was $216.8M. Net income was $24.3M. Revenue was up 19.5% from 2025-06-30 to 2025-09-30. CAI currently screens at market cap $5.22B.
Latest reported CLOV revenue for 2024-12-31 was $1.37B. Net income was -$43.0M. Revenue was up 8.8% from 2023-12-31 to 2024-12-31. CLOV currently screens at market cap $1.55B.
CAI currently screens at market cap $5.22B. CLOV currently screens at market cap $1.55B.
Not investment advice. Open the CAI and CLOV stock pages for the full models.
Not investment advice.